(Total Views: 488)
Posted On: 03/10/2021 8:47:31 AM
Post# of 145886
Re: ClosetInvestor #82509
The FDA approved the study as a phase 3 interventional and then allowed a BLA to be submitted based on that patient number. The study had a 92% success rate at 25 weeks blowing the p value out of the water.
(3)
(0)